Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132532) titled 'Clinical observation of clinical characteristics in patients with allergic rhinoconjunctivitis' on Sept. 15.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Bejing Tongren Hospital, Capital Medical Uniersity
Condition:
Allergic rhinoconjunctivitis (ARC), Allergic rhinitis (AR), allergic conjunctivitis (AC)
Intervention:
AR group:None
Healthy control group:None
AC group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: AR group:35;Healthy control group:35;AC group:35;ARC group:35;
Countries of Recruitment:
China
To kn...